About us
Our Vision
At Medip Analytics, our vision is to redefine the landscape of Biotech and Medtech by transforming challenges into opportunities. We aim to be a global beacon of innovation in health economics and outcomes research, guiding companies to not only navigate the complexities of the healthcare industry but to thrive within it. Our ambition is to lead the charge in demonstrating the undeniable value and effectiveness of medical technologies, thereby facilitating their swift adoption and integration into healthcare systems worldwide. Through our efforts, we envision a future where every medical technology can be fully realized for its potential to enhance health outcomes and optimize healthcare resource use.
Our Mission
Our mission at Medip Analytics is to empower companies by providing dynamic, evidence-based analytics that showcase the unique benefits and cost-effectiveness of their technologies. We are dedicated to delivering adaptable, comprehensive solutions tailored to the diverse needs of healthcare stakeholders, including local hospitals, key opinion leaders, payers, and national healthcare systems.
Grounded in health economics and outcomes research (HEOR), our experienced scientific team, with over a decade of expertise and a robust publication history, crafts compelling comparisons between new medical technologies and existing standards of care. Our work underscores the impact and value of medical innovations, facilitating rapid market adoption, boosting sales success, and contributing to our clients' positive business outcomes. At Medip Analytics, we simplify the complexities of the diagnostics landscape, creating clear paths to success and advancing medical technology for better health outcomes.
Founders
Tim Govers, PhD
CEO | HTA expert | Business developer
Tim Govers has a PhD in the use of decision models to make health care decisions for both the population and individual patients. After obtaining his PhD, he analyzed the added value of medical products for a great number of medical companies from his role at the Radboudumc and MedValue. In this role, he performed and supervised many model-based analyses of the value of diagnostic and prognostic tests.
Stan Wijn, PhD
CTO | Modeling expert | Software developer
Stan Wijn completed his PhD research on the analysis of the added value of medical interventions in subgroups of the population using a wide variety of statistical approaches. He has developed various applications that are used to demonstrate the value of medical interventions to healthcare professionals, such as physicians. He has also developed predictive algorithms to make predictions about treatment outcomes for patients.
Over 12 years of experience in health technology assessment, software development and data-analytics
All the right tools for the dynamic assessment of the value of a technology
Our Experiences
Medip Analytics has a wide experience over technologies and disease areas.
>7
Technologies
- Liquid biopsies
- (Epi)genetic markers
- Imaging techniques
- Image-guided therapies
- AI Algorithms
- Devices
- Implants
- and more..
>18
Disease areas
- Airway infections
- Bladder cancer
- Breast cancer
- Cardiac arrhythmias
- Colorectal cancers
- COPD
- Dementia
- Endometrial cancer
- Endometriosis
- Head and neck cancer
- Leukemia
- Lung cancer
- Melanoma
- Meniscus injuries
- Prostate cancer
- Schwannoma
- Stroke detection
- Ulcerative colitis
- and more..
Partners
Ready to Unlock you product's potential?
Schedule a demo to see how Medip Software can drive your product's development and market success.
